期刊簡介 | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | EXPERIMENTAL HEMATOLOGY LetPub Score 6.3
50 ratings
Rate
Reputation 7.6 Influence 5.1 Speed 7.0 | ||||||||||||||||||||||||||||||||
期刊簡稱 | EXP HEMATOL | ||||||||||||||||||||||||||||||||
ISSN | 0301-472X | ||||||||||||||||||||||||||||||||
E-ISSN | 1873-2399 | ||||||||||||||||||||||||||||||||
h-index | 114 | ||||||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||||||
自引率 (2023-2024) | 4.00%自引率趨勢 | ||||||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||||||
官方網站 | http://www.journals.elsevier.com/experimental-hematology/ | ||||||||||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/EXPHEM | ||||||||||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||||||||||
出版商 | Elsevier Inc. | ||||||||||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||||||||||
創刊年 | 1973 | ||||||||||||||||||||||||||||||||
每年文章數 | 64每年文章數趨勢 | ||||||||||||||||||||||||||||||||
黃金OA百分比 | 64.06% | ||||||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0301-472X%5BISSN%5D | ||||||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) 來自Elsevier的數據: Average 8.7 Week(s) | ||||||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Moderate 來自Elsevier的數據: 57% | ||||||||||||||||||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 12.7 Week(s) | ||||||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[EXPERIMENTAL HEMATOLOGY] 的評論 | 撰寫評論 |
作者: 五轮恨玉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-26 13:02:18 評論於 Do you accept cases?(0) 讚! | 五轮恨玉 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 20:56:47 評論於 3-5 suggested journals(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 10:08:28 評論於 Authors should first search and analyze in the SCI and Scopus databases; then, carefully read the submission guidelines of the journal they are preparing to submit to, and carefully review the recent issues and related articles of the journal to confirm if their submission aligns with the content(0) 讚! | 维尔娜菲茨杰拉德 |
作者: Oswald Edie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 14:57:01 評論於 How to evaluate the impact factor of your own article, or how to better position your article?(0) 讚! | Oswald Edie |
作者: 平原文波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 21:46:31 評論於 Which ones are more appropriate to choose when selecting the periodical?(0) 讚! | 平原文波 |
作者: Felix Jackson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-08-30 12:45:25 評論於 I don't know how to pay the fee either. Have you figured it out?(0) 讚! | Felix Jackson |
作者: 水桥友柳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-07-27 13:57:22 評論於 How can I pay the review fee? The editorial department only sent a link, but I can't pay(0) 讚! | 水桥友柳 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-18 23:31:43 評論於 Everything can only hope for next year, after all, as long as the overall trend is upward, there is no need to worry. Even if it rises only a little each year, it will accumulate over time, which is not bad(0) 讚! | 凌霄高洁 |
作者: 玄冰元化 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-08-01 23:14:22 評論於 After reading several articles in this magazine, I feel that the quality of the articles is very high, even higher than the usual 4-5 level. Why is the IF so low?(0) 讚! | 玄冰元化 |
作者: 百花怜容 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-04-09 10:30:57 評論於 Review Speed: 1.0 Experience Sharing: Submitted on January 5, 2016. Revised on February 6, 2016. Submitted again after major revision on March 15, 2016. Minor revision on April 2, 2016. Accepted on April 8, 2016. I have revised this article many times in terms of both language and ideas, so I am very happy that it was finally accepted. A $50 review fee was required when submitting. The reviewer mainly pointed out that certain aspects of my experiment were not rigorous enough and that the discussion section did not delve into the results(0) 讚! | 百花怜容 |
作者: 碧桃翰采 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-04-04 09:48:24 評論於 Can I ask, do we need to pay the layout fee when submitting the manuscript? It would be really unfortunate if it doesn't get accepted... If color figures are divided into A, B, and C, should they be counted as 1 figure or 3 figures? Thank you!(0) 讚! | 碧桃翰采 |
作者: 猫巷少女安然 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-06-20 10:05:49 評論於 Review speed: 2.0 | Submission hit rate: 75.0 Experience sharing: Submitted after the new year, waited for 2 months, minor revisions, and got accepted(0) 讚! | 猫巷少女安然 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-04-25 21:15:17 評論於 First instance replied in 4 weeks, minor modifications, accepted within 3 days after modification(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-07-30 17:43:34 評論於 So stable, just a little bit stronger, and you can break through the 3 points, right? It’s really so difficult(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-10-22 10:39:58 評論於 Review Speed: 3.0 | Submission success rate: 25.0 Sharing experience: The magazine charges a $50 review fee, which can be paid online with Visa or credit card. The initial review takes two months, and minor revisions are suggested. One reviewer found it interesting, while another suggested sending a letter. I did not agree to send a letter, and unfortunately my revised manuscript was rejected after around two months. Tragic~(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-11-28 12:34:16 評論於 Can we reach 3 points next year? Let's discuss(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us